Palvella Therapeutics (PVLA) Cash from Operations (QoQ) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -121.54% |
| Dec 31, 2025 | 37.56% |
| Sep 30, 2025 | -45.07% |
| Jun 30, 2025 | 19.74% |
| Mar 31, 2025 | -25.50% |
| Dec 31, 2024 | -96.68% |
| Sep 30, 2024 | -71.05% |
| Jun 30, 2024 | -45.46% |
| Mar 31, 2024 | -105.39% |
| Dec 31, 2023 | 310.30% |
| Sep 30, 2023 | 27.61% |
| Jun 30, 2023 | -22.14% |
| Mar 31, 2023 | 14.98% |
| Dec 31, 2022 | -47.33% |
| Sep 30, 2022 | 43.65% |
| Jun 30, 2022 | 31.20% |
| Mar 31, 2022 | -106.90% |
| Dec 31, 2021 | 24.44% |
| Sep 30, 2021 | -148.43% |
| Jun 30, 2021 | 346.38% |
| Mar 31, 2021 | 9.53% |
| Dec 31, 2020 | -77.24% |
| Sep 30, 2020 | 22.58% |
| Jun 30, 2020 | 35.38% |
| Mar 31, 2020 | -8.28% |
| Dec 31, 2019 | -10.45% |
| Sep 30, 2019 | -17.88% |
| Jun 30, 2019 | 28.96% |
| Mar 31, 2019 | -66.79% |
| Dec 31, 2018 | 36.92% |
| Sep 30, 2018 | -59.76% |
| Jun 30, 2018 | -128.68% |
| Mar 31, 2018 | 767.64% |
| Dec 31, 2017 | -113.34% |
| Sep 30, 2017 | 639.70% |
| Jun 30, 2017 | -125.31% |
| Mar 31, 2017 | 482.97% |
| Dec 31, 2016 | -88.21% |
| Sep 30, 2016 | 41.48% |
| Jun 30, 2016 | -401.49% |
| Mar 31, 2016 | 181.32% |
| Dec 31, 2015 | 29.54% |
| Sep 30, 2015 | -14.71% |
| Jun 30, 2015 | 14.19% |
| Sep 30, 2014 | 99.59% |
| Jun 30, 2014 | -714.13% |
| Mar 31, 2014 | -44,043.14% |
| Dec 31, 2013 | 78.99% |
| Sep 30, 2013 | -1,546.72% |